Form4insider filings, from the source

SEC Form 4 · accession 0000899243-15-002782

Aimmune Therapeutics, Inc. · AIMT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Aug 11, 2015
Accepted (ET)
Aug 11, 2015 · 11:46 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001631650

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, $0.0001 par valueF1,F2Aug 11, 2015C3,775,400—A3,775,400ISee Footnote
Common Stock, $0.0001 par valueF2Aug 11, 2015P312,500$16.00A4,087,900ISee Footnote
Common Stock, $0.0001 par valueF5Aug 11, 2015P312,500$16.00A312,500ISee Footnote
Common Stock, $0.0001 par valueF5Aug 11, 2015P17,035$20.4989A329,535ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B Convertible Preferred StockF1,F2,F6—Aug 11, 2015C3,775,400D——Common Stock3,775,4000I

Explanation of responses